Spinal Muscular Atrophy
Biogen Announces Positive Results from Higher Dose Spinraza Study in Spinal Muscular Atrophy Patients
Biogen, Spinraza, spinal muscular atrophy, SMA, higher dose, clinical trial, DEVOTE study
Actionable Insights Powered by AI
Biogen, Spinraza, spinal muscular atrophy, SMA, higher dose, clinical trial, DEVOTE study